The Latin America vaccine market was valued at USD 4,472.01 Million in 2024, driven by ongoing vaccine development by pharmaceutical firms. The market is expected to grow at a CAGR of 5.10% from 2025 to 2034, reaching USD 7,354.11 Million by 2034. Growth is supported by rising immunization efforts and advancements in vaccine research across the region. https://www.expertmarketresearch.com/reports/latin-america-vaccine-market